menu
    • menu

    Company profile for Wellbeing Digital Sciences

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Wellbeing Digital Sciences exists to make breakthrough treatments more easily accessible and offer patients transformational experiences. We operate medical clinics across North America to help our patients access plant-based medicines, psychedelics, and other forms of mental health care, all of which have the potential to heal them of their physical and/or emotional pain.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Wellbeing Digital SciencesCanada Flag
    Country
    Country
    Canada
    Address
    Address
    No 340-1917 West 4th Avenue Vancouver, BC V6J 1M7 Canada
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.wellbeingdigital.co/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/wellbeing-digital-sciences/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit
    Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit

    19 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230619984334/en

    BUSINESSWIRE
    19 Jun 2023
    Share Share
    Wellbeing Subsidiary KGK Science Receives Institutional Review Board Approval
    Wellbeing Subsidiary KGK Science Receives Institutional Review Board Approval

    11 Apr 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230411005484/en

    BUSINESSWIRE
    11 Apr 2023
    Share Share
    Wellbeing to Participate at the Cantor Fitzgerald Virtual Panel Discussion
    Wellbeing to Participate at the Cantor Fitzgerald Virtual Panel Discussion

    13 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230313005072/en

    BUSINESSWIRE
    13 Mar 2023
    Share Share
    KGK Science Announces Publication of Safety Studies on Paraxanthine
    KGK Science Announces Publication of Safety Studies on Paraxanthine

    15 Feb 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230215005168/en

    BUSINESSWIRE
    15 Feb 2023
    Share Share
    Wellbeing Subsidiary KGK Science Announces Successful Results of UP446
    Wellbeing Subsidiary KGK Science Announces Successful Results of UP446

    06 Dec 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221206005150/en

    BUSINESSWIRE
    06 Dec 2022
    Share Share
    Wellbeing Subsidiary KGK Science Submits CTA for Phase IIA Clinical Trial
    Wellbeing Subsidiary KGK Science Submits CTA for Phase IIA Clinical Trial

    30 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221130005210/en

    BUSINESSWIRE
    30 Nov 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search